The study aimed to identify factors like age, gender, and type of anxiety disorder that might influence the effectiveness of fluvoxamine treatment for anxiety in children and adolescents.
Analysis of data from a double-blind trial showed that only lower baseline depression scores (from parents) were linked to better treatment outcomes, while social phobia and higher severity of illness were associated with poorer responses.
The findings suggest that demographic and socioeconomic factors did not significantly impact treatment effects, but the presence of depressive symptoms in anxious children may require further investigation in future studies.